Novel manifestations of immune dysregulation and granule defects in gray platelet syndrome
Open Access
- 22 October 2020
- journal article
- research article
- Published by American Society of Hematology in Blood
- Vol. 136 (17), 1956-1967
- https://doi.org/10.1182/blood.2019004776
Abstract
Gray platelet syndrome (GPS) is a rare recessive disorder caused by biallelic variants in NBEAL2 and characterized by bleeding symptoms, the absence of platelet α-granules, splenomegaly, and bone marrow (BM) fibrosis. Due to the rarity of GPS, it has been difficult to fully understand the pathogenic processes that lead to these clinical sequelae. To discern the spectrum of pathologic features, we performed a detailed clinical genotypic and phenotypic study of 47 patients with GPS and identified 32 new etiologic variants in NBEAL2. The GPS patient cohort exhibited known phenotypes, including macrothrombocytopenia, BM fibrosis, megakaryocyte emperipolesis of neutrophils, splenomegaly, and elevated serum vitamin B12 levels. Novel clinical phenotypes were also observed, including reduced leukocyte counts and increased presence of autoimmune disease and positive autoantibodies. There were widespread differences in the transcriptome and proteome of GPS platelets, neutrophils, monocytes, and CD4 lymphocytes. Proteins less abundant in these cells were enriched for constituents of granules, supporting a role for Nbeal2 in the function of these organelles across a wide range of blood cells. Proteomic analysis of GPS plasma showed increased levels of proteins associated with inflammation and immune response. One-quarter of plasma proteins increased in GPS are known to be synthesized outside of hematopoietic cells, predominantly in the liver. In summary, our data show that, in addition to the well-described platelet defects in GPS, there are immune defects. The abnormal immune cells may be the drivers of systemic abnormalities such as autoimmune disease.This publication has 58 references indexed in Scilit:
- The Genotype-Tissue Expression (GTEx) projectNature Genetics, 2013
- Mutations in NBEAL2, encoding a BEACH protein, cause gray platelet syndromeNature Genetics, 2011
- Exome sequencing identifies NBEAL2 as the causative gene for gray platelet syndromeNature Genetics, 2011
- NBEAL2 is mutated in gray platelet syndrome and is required for biogenesis of platelet α-granulesNature Genetics, 2011
- Identifying a High Fraction of the Human Genome to be under Selective Constraint Using GERP++PLoS Computational Biology, 2010
- Gray platelet syndrome: natural history of a large patient cohort and locus assignment to chromosome 3pBlood, 2010
- The α‐granule proteome: novel proteins in normal and ghost granules in gray platelet syndromeJournal of Thrombosis and Haemostasis, 2010
- A method and server for predicting damaging missense mutationsNature Methods, 2010
- The platelet proteomeCurrent Opinion in Hematology, 2009
- Proteomic analysis of platelet α‐granules using mass spectrometryJournal of Thrombosis and Haemostasis, 2007